Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Revenue

In the year 2024, Ryvu Therapeutics had annual revenue of 101.96M PLN with 51.51% growth. Ryvu Therapeutics had revenue of 28.49M in the quarter ending December 31, 2024, with 60.89% growth.

• Revenue: 101.96M
• Revenue Growth: +51.51%
• P/S Ratio: 5.90
• Revenue / Employee: 310.86K
• Employees: 328
• Market Cap: 601.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	101.96M	34.67M	51.51%
Dec 31, 2023	67.30M	-1.14M	-1.67%
Dec 31, 2022	68.44M	33.02M	93.25%
Dec 31, 2021	35.41M	-1.54M	-4.16%
Dec 31, 2020	36.95M	3.23M	9.58%